Cellectis
CLLS
#7212
Rank
NZ$0.84 B
Marketcap
NZ$8.13
Share price
-1.05%
Change (1 day)
142.05%
Change (1 year)

Cellectis (CLLS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.42 Billion

According to Cellectis's latest financial reports the company's total liabilities are NZ$0.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cellectis - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.44 B13.45%
2023-12-31NZ$0.39 B85.22%
2022-12-31NZ$0.21 B-0.05%
2021-12-31NZ$0.21 B-4.24%
2020-12-31NZ$0.22 B33.86%
2019-12-31NZ$0.16 B120.59%
2018-12-31NZ$75.38 M9.5%
2017-12-31NZ$68.84 M-15.98%
2016-12-31NZ$81.94 M-33.76%
2015-12-31NZ$0.12 B2.08%
2014-12-31NZ$0.12 B173.62%
2013-12-31NZ$44.29 M14.7%
2012-12-31NZ$38.61 M-68.23%
2011-12-31NZ$0.12 B394.49%
2010-12-31NZ$24.58 M-16.61%
2009-12-31NZ$29.47 M18.22%
2008-12-31NZ$24.93 M84.89%
2007-12-31NZ$13.48 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
uniQure
QURE
NZ$1.14 B 171.94%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
NZ$2.31 B 451.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$15.95 B 3,697.55%๐Ÿ‡บ๐Ÿ‡ธ USA